| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $51.9M | +290.5% |
| SG&A Expense | $32.9M | +570.7% |
| Operating Income | -$189.5M | -3005.8% |
| Pre-tax Income | -$173.1M | -848.2% |
| Income Tax | $933K | — |
| Net Income | -$174.0M | -1298.4% |
| EPS (Basic) | -$0.68 | -750.0% |
| EPS (Diluted) | -$0.68 | -750.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $49.1M | — |
| Short-term Investments | $178.8M | — |
| Current Assets | $312.2M | — |
| Total Assets | $312.9M | +31.7% |
| Current Liabilities | $24.9M | +425.9% |
| Total Liabilities | $26.0M | -28.6% |
| Stockholders' Equity | $286.9M | +902.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$59.5M | -3873.2% |
| Capital Expenditures | $476K | — |
| Investing Cash Flow | -$258.5M | -5519.1% |
| Financing Cash Flow | $352.7M | +7567.5% |
| Free Cash Flow | -$59.9M | -3905.0% |